Drug
Glecaprevir Pibrentasvir Adult Formulation
Glecaprevir Pibrentasvir Adult Formulation: highest development phase Phase 2/3, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| Glecaprevir/Pibrentasvir Adult Formulation NCT03067129 | Phase 2/3 | Hepatitis C Virus (HCV) |
Latest
No recent events.
Follow Glecaprevir Pibrentasvir Adult Formulation on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.